Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Prostatic Neoplasms

Genital Neoplasms, Male

Urogenital Neoplasms

Genital Diseases

Genital Diseases, Male

Urogenital Diseases

Prostatic Diseases

Male Urogenital Diseases

Subjects will be asked to complete baseline surveys. Once the surveys are completed, subjects will review the Decision Aid tool with a study team member. Once the subjects have gone through the tool, study team members will answer any additional questions he may have regarding the tool. The subjects will then discuss with the investigator various cancer management options, quality of life implications, and any questions the subjects may have regarding cancer management options. Subjects that are ready may make a cancer management decision at this time, or choose to wait until their next scheduled visit. Subjects will be followed at subsequent urology clinic visits for up to 6 months. Subjects will complete follow-up surveys at the 3, 6, 9 and 12 month visits.

Subjects will be given an I-pad with the decision aid program on it. A member of the study team will enter some preliminary information, then the subject will be able to review the tool with his doctor.

Decision Aid Tool

patients will be given baseline surveys to gather demographic information and readiness to make a decision regarding prostate cancer care

baseline survey

at 3, 6, 9, and 12 months patients will be given follow-up surveys regarding prostate cancer care

follow-up surveys

Simon P Kim, MD, MPH

A pilot study testing the effect of an in-visit English and Spanish language decision aid for Hispanic-Latino men using best practices of cultural tailoring to be used in urology practice. Subjects will be followed for approximately 1 year during standard care in-clinic office visits. Study results and subject surveys will be analyzed to determine clinical utility of the tool.

The objective of this research is to determine the effect of a culturally tailored decision aid tool on the cancer treatment decisions of Hispanic-Latino patients.

The specific aims are:

i. To develop and pilot test in an uncontrolled fashion an in-visit English and Spanish language decision aid for Hispanic-Latino men using best practices of cultural tailoring to be used in urology practice ii. To pilot and test the impact of a culturally tailored, English and Spanish language version of the Prostate Choice in-visit decision aid on decision quality, knowledge, and quality of life in low-income Hispanic/Latino patients diagnosed with localized prostate cancer iii. To assess the barriers and facilitators of decision aid use including the relative contribution of language-concordance on 1-year practice implementation parameters.

Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer

Development and Testing of a Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer

Decisional quality will be measured by the O'Connor Decisional Conflict Scale

Prostate cancer knowledge will be measured by the Knowledge Measurement Tool

Patient satisfaction will be measured by the CAPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) patient satisfaction measurement tool

Health-related quality of life will be measured by the EPIC (Expanded Prostate Cancer Index Composite) assessment tool

Case Comprehensive Cancer Center

Skin and Connective Tissue Diseases

Melanoma

Skin Neoplasms

Skin Diseases

MC1R genotyping

The website includes three educational modules about genetic testing with corresponding knowledge questions.

MC1R Testing Website

Baseline Survey

Jennifer Hay, PhD

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Interest and Impact of Skin Cancer Genetic Testing

PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS

Memorial Sloan Kettering Cancer Center

Subjects received an infusion in an outpatient infusion center.

Subjects received an infusion in an inpatient infusion center.

A survey that measures participant satisfaction will be offered to participants during infusion at baseline.

Semi-structured interviews will be conducted in the same infusion spaces.

Semi-structured interviews

A survey that measures participant satisfaction will be offered to participants during following infusion.

Follow-up Survey

Daniel Kleissler

Jacob Stein

The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.

Young Adult Infusion Space Experience Satisfaction Survey

Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital

General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces.

Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

Subject satisfaction with the built environment will be measured with a survey item specific to the built environment administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.

Responses are rated on a Likert scale from 0 to 2. Scores will be summarized using frequency tables and percentages.

Subject satisfaction with staff interaction will be measured with a survey item specific to staff interactions administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.

Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

Subject satisfaction with mental health will be measured with survey items regarding emotional support and comfort administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.

Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer	NCT03157947	Prostate Cancer	Decision Aid To... baseline survey follow-up surve...	18 Years -	Case Comprehensive Cancer Center
Interest and Impact of Skin Cancer Genetic Testing	NCT02941900	Non-melanoma Sk...	MC1R genotyping MC1R Testing We... Baseline Survey	18 Years -	Memorial Sloan Kettering Cancer Center
Young Adult Infusion Space Experience Satisfaction Survey	NCT05720546	Cancer	Baseline Survey Semi-structured... Follow-up Surve...	18 Years - 39 Years	UNC Lineberger Comprehensive Cancer Center

Spots Global Cancer Trial Database for baseline survey